HK Stock Market Move | GOODBABY INTL (01086) rose nearly 4%, with expected net profit growth year-on-year to approximately HKD 260 million to about HKD 300 million.
Goodbaby International (01086) rose nearly 4%, and as of the time of writing, it increased by 3.83%, reaching HK$0.95, with a transaction value of HK$2.5174 million.
GOODBABY INTL (01086) rose nearly 4%, and as of the time of this report, it is up 3.83%, priced at HK$0.95, with a transaction amount of HK$2.5174 million.
In terms of news, recently, GOODBABY INTL announced that based on a preliminary assessment of currently available information (including the Group's unaudited management accounts), the Group expects to achieve a net profit of approximately HK$260 million to approximately HK$300 million for the six months ending June 30, 2026 (the period), compared to a net profit of approximately HK$106 million in the same period of 2025. The increase in net profit is mainly due to refunds of tariffs from the U.S. government.
Related Articles

Beijing Wantai Biological Pharmacy Enterprise (603392.SH) subsidiary's nine-valent HPV vaccine has obtained marketing approval in Thailand.

NEW AMANTE (08412) will issue 24,449,500 subscription shares on August 11.

Wanbangde Pharmaceutical Holding Group (002082.SZ) subsidiary's product, Huperzine A Injection, has been selected for inter-provincial alliance procurement.
Beijing Wantai Biological Pharmacy Enterprise (603392.SH) subsidiary's nine-valent HPV vaccine has obtained marketing approval in Thailand.

NEW AMANTE (08412) will issue 24,449,500 subscription shares on August 11.

Wanbangde Pharmaceutical Holding Group (002082.SZ) subsidiary's product, Huperzine A Injection, has been selected for inter-provincial alliance procurement.

RECOMMEND





